BioCentury
ARTICLE | Company News

Axys, Bayer deal

January 16, 2001 8:00 AM UTC

Under an amendment to the companies’ 1994 tryptase inhibitor collaboration, AXPH will pay BAYG fees for the exclusive right to develop APC 2059 tryptase inhibitor as an inhaled product to treat asthm...